Testing effectiveness (Phase 2)Ended earlyNCT00117845
What this trial is testing
Phase II Study of the Efficacy and Toxicity of Ontak(Registered Trademark) (Denileukin Diftitox) in the Therapy of Adult T-Cell Leukemia
Who this might be right for
Leukemia, Adult T-Cell
National Cancer Institute (NCI) 17